Snapchat is in discussions to raise a new round of financing from Alibaba in a deal that could value the mobile-messaging app at about $10 billion.
When Italian academic Alberto Micalizzi moved into the world of hedge funds, he was following a familiar path. But the move has ended badly.
Regeneron Pharmaceuticals and Sanofi are spending $67.5 million to buy a special voucher held by BioMarin Pharmaceuticals in a bid to hasten regulatory review of their new cholesterol drug.
Good-bye Detroit, hello Hawaii. With markets at record levels and wealth-management fees rising, Wall Street is once again sending top brokers to luxury destinations.
Brazilian mining company Vale SA reported lower-than-expected net profit in the second quarter as prices for iron ore fell to a four-year low and the company continued to write off assets.
Hyatt Hotels Corp. said its second-quarter profit declined 34% as results were weighed down by expenses despite improvement in rates, occupancy and revenue.
McKesson Corp. said its fiscal first-quarter earnings fell 5% despite the drug wholesaler's strong revenue growth.
Anheuser-Busch InBev reported that strong sales volume growth and cost cuts boosted net profit in the second quarter, driven in part by World Cup sales.
Boeing plans to build a new version of its flagship 787 Dreamliner jet exclusively at its nonunion factory in South Carolina.